| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |